Glenn Thorpe, senior vice president sales, Datwyler, looks at why the US is a strong pillar of pharmaceutical manufacturing.
USA flag
The US is already a key market for pharmaceutical manufacturing, and will gain even more importance in the next five to 10 years. The largest number of biotech companies worldwide can be found in the US, investing more than $75 billion per year. Those investments are set to be growing — not only due to further developments in the biotech sector, but also due to a shift from foreign-based to home-grown facilities and manufacturing sites.